Table 1 Cohort characteristics for ALSPAC and CHDS.
Cohort | Age (y) | N | Sample | Female (%) | PCE | PCTE | PTE | Tobacco smoking | Cannabis user |
|---|---|---|---|---|---|---|---|---|---|
ALSPAC | |||||||||
Timepoint 1 | 0 | 858 | Cord blood | 448 (52.21%) | 10 (1.51%) | 30 (3.14%) | 168 (19.58%) | ||
Timepoint 2 | 7 | 924 | Whole blood | 473 (51.19%) | 9 (1.08%) | 22 (3.46%) | 184 (19.91%) | ||
Timepoint 3 | 15-17 | 922 | Whole blood | 484 (52.49%) | 11 (1.19%) | 21 (3.57%) | 182 (19.73%) | ||
CHDS | |||||||||
Timepoint 1 | ~27 | 98 | Whole blood | 27 (27.5%) | 4 (4.08%) | 13 (13.2%) | 55 (56.1%) | 28 (28.5%) | 37 (37.5%) |